US 11890340
Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders
granted A61KA61K2039/505A61K31/7088
Quick answer
US patent 11890340 (Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K31/7088, A61K31/711, A61K31/713